TOLDEC, el proyecto que quiere reeducar las defensas para que no ataquen la mielina I Yolanda Blanco

Dr. Yolanda Blanco, coordinator of the Neuroimmunology and Multiple Sclerosis Unit at Hospital Clínic de Barcelona, ​​emphasizes that research into cell therapies is experiencing a decisive moment, opening up a hopeful future for people with multiple sclerosis. Projects such as TOLDEC, initially promoted by the GAEM Foundation, seek to re-educate the immune system using patient-specific cells modified in the laboratory to stop them from attacking myelin. After demonstrating safety in Phase 1, the trial is moving into Phase 2 with relapsing-remitting patients, although its development requires significant social and financial support due to the high costs. Despite the challenges, Blanco sends an optimistic message: there are teams working at all stages of the disease, and cell therapies represent a true gateway to hope.